Cargando…
Fluvoxamine, melatonin and COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779245/ https://www.ncbi.nlm.nih.gov/pubmed/33392622 http://dx.doi.org/10.1007/s00213-020-05753-z |
| _version_ | 1783631292809609216 |
|---|---|
| author | Anderson, George M. |
| author_facet | Anderson, George M. |
| author_sort | Anderson, George M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7779245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77792452021-01-04 Fluvoxamine, melatonin and COVID-19 Anderson, George M. Psychopharmacology (Berl) Letter to the Editor Springer Berlin Heidelberg 2021-01-04 2021 /pmc/articles/PMC7779245/ /pubmed/33392622 http://dx.doi.org/10.1007/s00213-020-05753-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Anderson, George M. Fluvoxamine, melatonin and COVID-19 |
| title | Fluvoxamine, melatonin and COVID-19 |
| title_full | Fluvoxamine, melatonin and COVID-19 |
| title_fullStr | Fluvoxamine, melatonin and COVID-19 |
| title_full_unstemmed | Fluvoxamine, melatonin and COVID-19 |
| title_short | Fluvoxamine, melatonin and COVID-19 |
| title_sort | fluvoxamine, melatonin and covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779245/ https://www.ncbi.nlm.nih.gov/pubmed/33392622 http://dx.doi.org/10.1007/s00213-020-05753-z |
| work_keys_str_mv | AT andersongeorgem fluvoxaminemelatoninandcovid19 |